Symbol
VTGN on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
616,749 shares
Security Ownership %
1.5%
Shares, Excluding Options vs Price
Value, Excluding Options

StemPoint Capital LP ownership in Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

17 Feb 2026 - StemPoint Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 616,749 shares of Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN). This represents 1.5% ownership of the company. In their previous filing dated 14 Feb 2025, STEMPOINT CAPITAL LP had reported owning 2,328,492 shares, indicating a decrease of +74%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.